Anti-cIAP2 antibody
| Name | Anti-cIAP2 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab137393 |
| Prices | $378.00 |
| Sizes | 100 µl |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB IHC-P |
| Species Reactivities | Human |
| Antigen | Recombinant fragment, corresponding to a region within amino acids 314-538 of Human cIAP2 (Uniprot ID: Q13489) |
| Description | Rabbit Polyclonal |
| Gene | BIRC3 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
All lanes : Anti-cIAP2 antibody (ab137393) at 1/1000 dilutionLane 1 : 293T whole cell lysateLane 2 : A431 whole cell lysateLane 3 : H1299 whole cell lysateLane 4 : HeLa whole cell lysateLane 5 : HepG2 whole cell lysateLane 6 : MOLT4 whole cell lysateLysates/proteins at 30 µg per lane.
Immunohistochemical analysis of paraffin-embedded Human SW480 xenograft tissue labelling cIAP2 with ab137393 at 1/100 dilution.
Product References
Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a - Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a
Wagner L, Marschall V, Karl S, Cristofanon S, Zobel K, Deshayes K, Vucic D, Debatin KM, Fulda S. Oncogene. 2013 Feb 21;32(8):988-97.
Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced - Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced
Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Hacker S, Vellanki SH, Lausen J, Debatin KM, Fulda S. Oncogene. 2012 Nov 1;31(44):4677-88.